Abstract
Aims
The objective of this study is to investigate the association between multiple antihypertensive use and mortality in residents with diagnosed hypertension, and whether dementia and frailty modify this association.
Methods
This is a two-year prospective cohort study of 239 residents with diagnosed hypertension receiving antihypertensive therapy across six residential aged care services in South Australia. Data were obtained from electronic medical records, medication charts and validated assessments. The primary outcome was all-cause mortality and the secondary outcome was cardiovascular-related hospitalizations. Inverse probability weighted Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause mortality. Covariates included age, sex, dementia severity, frailty status, Charlson’s comorbidity index and cardiovascular comorbidities.
Results
The study sample (mean age of 88.1 ± 6.3 years; 79% female) included 70 (29.3%) residents using one antihypertensive and 169 (70.7%) residents using multiple antihypertensives. The crude incidence rates for death were higher in residents using multiple antihypertensives compared with residents using monotherapy (251 and 173/1000 person-years, respectively). After weighting, residents who used multiple antihypertensives had a greater risk of mortality compared with monotherapy (HR 1.40, 95%CI 1.03–1.92). After stratifying by dementia diagnosis and frailty status, the risk only remained significant in residents with diagnosed dementia (HR 1.91, 95%CI 1.20–3.04) and who were most frail (HR 2.52, 95%CI 1.13–5.64). Rate of cardiovascular-related hospitalizations did not differ among residents using multiple compared to monotherapy (rate ratio 0.73, 95%CI 0.32–1.67).
Conclusions
Multiple antihypertensive use is associated with an increased risk of mortality in residents with diagnosed hypertension, particularly in residents with dementia and among those who are most frail.
Similar content being viewed by others
References
Weiss J, Freeman M, Low A et al (2017) Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: a systematic review and meta-analysis. Ann Intern Med 166:419–429. https://doi.org/10.7326/m16-1754
Lim KK, Sivasampu S, Khoo EM (2015) Antihypertensive drugs for elderly patients: a cross-sectional study. Singapore Med J 56:291–297. https://doi.org/10.11622/smedj.2015019
Zeglin Magdalena A, Pacos Jason, Bisognano JD (2009) Hypertension in the very elderly: brief review of management. Cardiol J 16:379–385
Aronow WS, Fleg JL, Pepine CJ et al (2011) ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens 5:259–352. https://doi.org/10.1016/j.jash.2011.06.001
Hakala SM, Tilvis RS, Strandberg TE (1997) Blood pressure and mortality in an older population: a 5-year follow-up of the Helsinki Ageing Study. Eur Heart J 18:1019–1023
Briasoulis A, Agarwal V, Tousoulis D et al (2014) Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies. Heart 100:317–323
Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913
Lernfelt B, Svanborg A (2002) Change in blood pressure in the age interval 70–90. Late blood pressure peak related to longer survival. Blood Press 11:206–212
Delgado J, Masoli JAH, Bowman K et al (2017) Outcomes of treated hypertension at age 80 and older: cohort analysis of 79,376 individuals. J Am Geriatr Soc 65:995–1003. https://doi.org/10.1111/jgs.14712
Williamson JD, Supiano MA, Applegate WB et al (2016) Intensive vs Standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years: a randomized clinical trial. JAMA 315:2673–2682. https://doi.org/10.1001/jama.2016.7050
Beckett NS, Peters R, Fletcher AE et al (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887–1898
National Heart Foundation of Australia (2016) Guideline for the diagnosis and management of hypertension in adults—2016. National Heart Foundation of Australia, Melbourne
Tu K, Anderson LN, Butt DA et al (2014) Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions. Can J Cardiol 30:647–652. https://doi.org/10.1016/j.cjca.2014.03.017
Mosnaim AD, Abiola R, Wolf ME et al (2010) Etiology and risk factors for developing orthostatic hypotension. Am J Ther 17:86–91. https://doi.org/10.1097/MJT.0b013e3181a2b1bb
Sun BC, Emond JA, Camargo CA Jr (2004) Characteristics and admission patterns of patients presenting with syncope to US emergency departments, 1992–2000. Acad Emerg Med 11:1029–1034
Ogliari G, Westendorp RG, Muller M et al (2015) Blood pressure and 10-year mortality risk in the Milan Geriatrics 75 + Cohort Study: role of functional and cognitive status. Age Ageing 44:932–937. https://doi.org/10.1093/ageing/afv141
Odden MC, Peralta CA, Haan MN et al (2012) Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med 172:1162–1168. https://doi.org/10.1001/archinternmed.2012.2555
Onder G, Landi F, Fusco D et al (2014) Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project. Drugs Aging 31:33–45
Onder G, Vetrano DL, Marengoni A et al (2018) Accounting for frailty when treating chronic diseases. Eur J Intern Med 56:49–52. https://doi.org/10.1016/j.ejim.2018.02.021
Vetrano DL, Palmer KM, Galluzzo L et al (2018) Hypertension and frailty: a systematic review and meta-analysis. BMJ Open 8:e024406. https://doi.org/10.1136/bmjopen-2018-024406
Welsh TJ, Gladman JR, Gordon AL (2014) The treatment of hypertension in people with dementia: a systematic review of observational studies. BMC geriatrics 14:19. https://doi.org/10.1186/1471-2318-14-19
Palmer K, Villani ER, Vetrano DL et al (2019) Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med 10:9–36. https://doi.org/10.1007/s41999-018-0124-5
Benetos A, Labat C, Rossignol P et al (2015) Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE Study. JAMA Intern Med 175:989–995
Sluggett JK, Ilomaki J, Seaman KL et al (2017) Medication management policy, practice and research in Australian residential aged care: current and future directions. Pharmacol Res 116:20–28. https://doi.org/10.1016/j.phrs.2016.12.011
The National Centre for Social and Economic Modelling NATSEM (2017) Economic cost of dementia in Australia 2016–2056. Alzheimer’s Australia, Canberra
Theou O, Tan EC, Bell JS et al (2016) Frailty levels in residential aged care facilities measured using the frailty index and FRAIL-NH scale. J Am Geriatr Soc 64:e207–e212. https://doi.org/10.1111/jgs.14490
Tan ECK, Visvanathan R, Hilmer SN et al (2014) Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol. BMJ Open 4:e005757
WHO Collaborating Centre for Drug Statistics Methodology (2019) ATC classification index with DDDs, Oslo, Norway
Clark CM, Ewbank DC (1996) Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease. Alzheimer Dis Assoc Disord 10:31–39
Kaehr E, Visvanathan R, Malmstrom TK et al (2015) Frailty in nursing homes: the FRAIL-NH scale. J Am Med Dir Assoc 16:87–89. https://doi.org/10.1016/j.jamda.2014.12.002
Buntinx F, Niclaes L, Suetens C et al (2002) Evaluation of Charlson’s comorbidity index in elderly living in nursing homes. J Clin Epidemiol 55:1144–1147
Yang D, Dalton JE (2012) A unified approach to measuring the effect size between two groups using SAS. SAS Global Forum
Ravindrarajah R, Dregan A, Hazra NC et al (2017) Declining blood pressure and intensification of blood pressure management among people over 80 years: cohort study using electronic health records. J Hypertens 35:1276–1282. https://doi.org/10.1097/hjh.0000000000001291
Tan EC, Bell JS, Lu CY et al (2016) National trends in outpatient antihypertensive prescribing in people with dementia in the United States. J Alzheimers Dis 54:1425–1435. https://doi.org/10.3233/jad-160470
van der Wardt V, Logan P, Conroy S et al (2014) Antihypertensive treatment in people with dementia. J Am Med Dir Assoc 15:620–629. https://doi.org/10.1016/j.jamda.2014.03.005
Mossello E, Pieraccioli M, Nesti N et al (2015) Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 175:578–585. https://doi.org/10.1001/jamainternmed.2014.8164
Streit S, Poortvliet RKE, Gussekloo J (2018) Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old-data from the Leiden 85-plus study. Age Ageing. https://doi.org/10.1093/ageing/afy072
Odden MC, Beilby PR, Peralta CA (2015) Blood pressure in older adults: the importance of frailty. Curr Hypertens Rep 17:55. https://doi.org/10.1007/s11906-015-0564-y
Warwick J, Falaschetti E, Rockwood K et al (2015) No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the hypertension in the very elderly trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med 13:78. https://doi.org/10.1186/s12916-015-0328-1
Russo G, Liguori I, Aran L et al (2018) Impact of SPRINT results on hypertension guidelines: implications for “frail” elderly patients. J Hum Hypertens 32:633–638. https://doi.org/10.1038/s41371-018-0086-6
Fried LP, Ferrucci L, Darer J et al (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol Ser A 59:M255–M263. https://doi.org/10.1093/gerona/59.3.M255
Benetos A, Gautier S, Labat C et al (2012) Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (predictive values of blood pressure and arterial stiffness in institutionalized very aged population) study. J Am Coll Cardiol 60:1503–1511. https://doi.org/10.1016/j.jacc.2012.04.055
Ravindrarajah R, Hazra NC, Hamada S et al (2017) Systolic blood pressure trajectory, frailty, and all-cause mortality > 80 years of age: cohort study using electronic health records. Circulation 135:2357–2368. https://doi.org/10.1161/circulationaha.116.026687
Kantoch A, Gryglewska B, Wojkowska-Mach J et al (2018) Treatment of cardiovascular diseases among elderly residents of long-term care facilities. J Am Med Dir Assoc 19:428–432. https://doi.org/10.1016/j.jamda.2017.12.102
Schisterman EF, Cole SR, Platt RW (2009) Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology (Cambridge, Mass) 20:488–495. https://doi.org/10.1097/EDE.0b013e3181a819a1
Australian Institute of Health and Welfare (2017) GEN fact sheet 2015–16: people leaving aged care. AIHW, Canberra
Acknowledgements
The authors thank Resthaven staff and residents for their participation in this study.
Funding
The data used for this study were collected with support from the Alzheimer Australia Dementia Research Foundation via the Resthaven Incorporated Dementia Research Award. ECKT was supported by an Australian National Health and Medical Research Council-Australian Research Council (NHMRC-ARC) Dementia Research Development Fellowship (APP1107381). JSB was supported by an NHMRC Dementia Leadership Fellowship. JI was supported by an NHMRC Early Career Fellowship. NJ was supported by an Australian Government Research Training Program Scholarship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
All procedures performed in this study were in accordance with the ethical standards of the Royal Australian College of General Practitioners National Research and Evaluation Ethics Committee and the Monash University Health Research Ethics Committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study. Where residents were unable to provide informed consent, consent was obtained from a guardian, next of kin, or significant other.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kerry, M., Bell, J.S., Keen, C. et al. Multiple antihypertensive use and risk of mortality in residents of aged care services: a prospective cohort study. Aging Clin Exp Res 32, 1541–1549 (2020). https://doi.org/10.1007/s40520-019-01336-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-019-01336-x